In summation, galectin-3 could be a valuable prognostic biomarker in the assessment of heart failure in children; however, the data are still sparse and further trials are necessary to evaluate the value of the biomarker and its relationship to hemodynamical dysfunction. This evidence concerns the gene LGALS3 and heart failure.